Bioplax Limited - Limited company accounts 23.2
Bioplax Limited - Limited company accounts 23.2
| REGISTERED NUMBER: |
| Report of the Director and |
| Unaudited Financial Statements for the Year Ended 31 December 2022 |
| for |
| Bioplax Limited |
| Bioplax Limited (Registered number: 05278706) |
| Contents of the Financial Statements |
| for the Year Ended 31 December 2022 |
| Page |
| Company Information | 1 |
| Report of the Director | 2 |
| Chartered Accountants' Report | 3 |
| Income Statement | 4 |
| Statement of Financial Position | 5 |
| Notes to the Financial Statements | 6 |
| Bioplax Limited |
| Company Information |
| for the Year Ended 31 December 2022 |
| DIRECTOR: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Endeavour House |
| 78 Stafford Road |
| Wallington |
| Surrey |
| SM6 9AY |
| Bioplax Limited (Registered number: 05278706) |
| Report of the Director |
| for the Year Ended 31 December 2022 |
| The director presents his report with the financial statements of the company for the year ended 31 December 2022. |
| PRINCIPAL ACTIVITY |
| The principal activity of the company in the year under review was that of holding patents and trademarks and to trade in the pharmaceutical industry. |
| DIRECTOR |
| This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies. |
| ON BEHALF OF THE BOARD: |
| Chartered Accountants' Report to the Director |
| on the Unaudited Financial Statements of |
| Bioplax Limited |
| In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Bioplax Limited for the year ended 31 December 2022 which comprise the Income Statement, Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given us. |
| As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance. |
| This report is made solely to the director of Bioplax Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Bioplax Limited and state those matters that we have agreed to state to the director of Bioplax Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Bioplax Limited and its director for our work or for this report. |
| It is your duty to ensure that Bioplax Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Bioplax Limited. You consider that Bioplax Limited is exempt from the statutory audit requirement for the year. |
| We have not been instructed to carry out an audit or a review of the financial statements of Bioplax Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. |
| Endeavour House |
| 78 Stafford Road |
| Wallington |
| Surrey |
| SM6 9AY |
| Bioplax Limited (Registered number: 05278706) |
| Income Statement |
| for the Year Ended 31 December 2022 |
| 2022 | 2021 |
| Notes | € | € |
| TURNOVER |
| Cost of sales |
| GROSS (LOSS)/PROFIT | ( |
) |
| Administrative expenses |
| OPERATING LOSS and |
| LOSS BEFORE TAXATION | ( |
) | ( |
) |
| Tax on loss |
| LOSS FOR THE FINANCIAL YEAR | ( |
) | ( |
) |
| Bioplax Limited (Registered number: 05278706) |
| Statement of Financial Position |
| 31 December 2022 |
| 2022 | 2021 |
| Notes | € | € |
| CURRENT ASSETS |
| Debtors | 6 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 7 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| 422,646 | 576,400 |
| The director acknowledges his responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the director and authorised for issue on |
| Bioplax Limited (Registered number: 05278706) |
| Notes to the Financial Statements |
| for the Year Ended 31 December 2022 |
| 1. | STATUTORY INFORMATION |
| Bioplax Limited is a |
| The presentation currency of the financial statements is the Euro (€). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Intangible assets |
| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
| Patents & trademarks have been fully amortised. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was NIL (2021 - NIL). |
| Bioplax Limited (Registered number: 05278706) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2022 |
| 4. | OPERATING LOSS |
| The operating loss is stated after charging: |
| 2022 | 2021 |
| € | € |
| Patents & trademarks amortisation |
| 5. | INTANGIBLE FIXED ASSETS |
| Patents & |
| trademarks |
| € |
| COST |
| At 1 January 2022 |
| and 31 December 2022 |
| AMORTISATION |
| At 1 January 2022 |
| and 31 December 2022 |
| NET BOOK VALUE |
| At 31 December 2022 |
| At 31 December 2021 |
| 6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2022 | 2021 |
| € | € |
| Trade debtors |
| Corporation tax |
| Social security and other taxes |
| Prepayments and accrued income |
| Prepayments |
| 7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2022 | 2021 |
| € | € |
| Trade creditors |
| Accruals and deferred income |
| 8. | CONTROLLING PARTY |
| The controlling party is Esperia Servizi Fiduciari SpA, whose Registered Office is Via Dante 16, 20121 Milan MI, Italy |